Excluding Other Drug-Positive Participants Changed Some Vaporized-THC Cognitive Findings

In the prescribed-flower study, excluding participants with other positive drug-screen indications narrowed the set of significant cognitive findings. The sensitivity analysis changed which conclusions were most stable.

The full sample had several affected measures

Before exclusions, post-cannabis changes were reported for Trail Making A, Trail Making B, a Trail Making ratio and a Stroop measure. Other cognitive tasks were nonsignificant. The initial battery therefore did not support either uniform impairment or uniform absence of change.

The restricted analysis retained fewer findings

Eight participants had a positive indication for substances other than THC at one or more testing points. After excluding them, the Trail Making A and B findings remained, while the other comparisons were no longer significant. This pattern differs from the oral study, where excluding other drug-positive participants did not change the reported results.

Sensitivity analysis is not proof of confounding

The change does not establish that another drug caused a particular effect: reducing a sample also changes precision. Screening indications do not supply a complete exposure timeline. The appropriate account reports both analyses and identifies which findings persisted. This research used human cognitive tasks relevant to driving, not a direct demonstration of collision risk. A result’s stability across an exclusion analysis strengthens a specific inference without validating every broader claim about the entire battery.

Related analysis: the study’s main findings and limitations.

Research cited

Stefanidis and colleagues. Elucidating the acute effects of medically prescribed oral and vaporised delta-9-tetrahydrocannabinol on cognitive functions important for driving. Drug and Alcohol Review (2025). DOI: 10.1111/dar.14060.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

A mouse cerebral-malaria experiment summarized in the CBD brain review reported memory findings when CBD was added to artesunate. The observation concerned adjunctive treatment in an infectious-disease model, rather than CBD alone as a general memory enhancer. The disease and co-treatment belonged in the result The review describes CBD treatment…

Spread the love

Read Article: CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Rat experiments summarized in the CBD brain review found different degrees of interference with CBD-related pain responses after serotonin-receptor blockade. The evidence did not establish one exclusive mechanism for every model. The diabetic and nerve-injury models differed In male diabetic rats, the review reports attenuation of mechanical allodynia with CBD…

Spread the love

Read Article: Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

An observational CBD study summarized in the brain-function review reported improvement in pain patients but had substantial participant loss and incomplete dosing information. Those limitations constrained attribution of the change to CBD. The clinical groups did not report one uniform response The review describes Gulbransen and colleagues’ exploratory quality-of-life study….

Spread the love

Read Article: Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us